Edition:
United Kingdom

Dynavax Technologies Corp (DVAX.OQ)

DVAX.OQ on NASDAQ Stock Exchange Capital Market

6.41USD
18 Apr 2019
Change (% chg)

$-0.02 (-0.31%)
Prev Close
$6.43
Open
$6.43
Day's High
$6.52
Day's Low
$6.23
Volume
310,708
Avg. Vol
295,029
52-wk High
$20.50
52-wk Low
$6.23

About

Dynavax Technologies Corporation is a clinical-stage immunotherapy company. The Company is focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $410.22
Shares Outstanding(Mil.): 64.00
Dividend: --
Yield (%): --

Financials

  DVAX.OQ Industry Sector
P/E (TTM): -- 109.48 62.40
EPS (TTM): -2.55 -- --
ROI: -85.19 7.96 11.78
ROE: -121.01 8.11 12.61

Earnings vs. Estimates